Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-902-6 | CAS number: 75-79-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- one-generation reproductive toxicity
- Remarks:
- based on generations indicated in Effect levels (migrated information)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Qualifier:
- according to guideline
- Guideline:
- other: USEPA OPPTS 870.3650
- GLP compliance:
- yes
Test material
- Reference substance name:
- Trimethoxy(methyl)silane
- EC Number:
- 214-685-0
- EC Name:
- Trimethoxy(methyl)silane
- Cas Number:
- 1185-55-3
- IUPAC Name:
- trimethoxy(methyl)silane
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD®(SD)IGS BR VAF/Plus®
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- ANIMAL RECEIPT AND ACCLIMATION
Ninety female and forty five male Crl:CD®(SD)IGS BR VAF/Plus® rats were received from Charles River Laboratories, Portage, MI. The animals were 9 weeks old. Upon receipt, each animal was inspected by animal resource personnel and animals judged to be in good health and suitable as test animals were quarantined for six days. During the quarantine period animal resource personnel observed each animal at least once daily. The attending veterinarian examined all animals before release from quarantine and documented the general state of animal health.
ANIMAL HOUSING
Animals were individually housed in suspended wire-mesh cages elevated over Bed-O’Cobs Alf-a’ bedding, during quarantine and throughout the course of the study, with the following exceptions. During cohabitation, reproductive group females were paired 1 to 1 with a male from the same treatment group in suspended wire-mesh cages elevated over Bed-O’Cobs Alf-a’ bedding. The animals were paired in the home cage of the male. On day 0 of gestation, reproductive group females were moved into shoebox cages containing Bed-O’ Cobs Combination bedding and remained there throughout the remainder of the study. The results of the manufacturer’s periodic analysis of the Bed-O’ Cobs Combination bedding were reviewed to ensure that there were no contaminants present at levels that would be expected to affect the outcome of the study. The cages, bedding/fecal pans were routinely cleaned, consistent with good husbandry practices.
DIET, DRINKING WATER AND MAINTENANCE
PMIcertified Rodent Diet #5002, manufactured by PMI Nutritional International, St. Louis, MO, was offered ad libitum except during functional observational battery assessment period. Males and toxicity group females were fasted prior to necropsy by removing food on the evening of the day before necropsy. The results of the manufacturer’s periodic analyses of the certified feed were reviewed to ensure that heavy metals and pesticides were not present in concentrations that would be expected to affect the outcome of the study.
Municipal water, further purified by reverse osmosis was available ad libitum except during performance of functional observational battery testing. The drinking water was monitored on at least a semi-annual basis to determine compliance with the U.S.E.P.A. drinking water standards. The most recent analysis was reviewed and there were no contaminants in the water known to be present at levels expected to interfere with the integrity of the study.
ENVIRONMENTAL CONDITIONS
Animals were housed in an environmentally controlled animal room (12-hour fluorescent light/dark cycle, 68.3-72.5 oF, 36.0-62.0% relative humidity, 10-15 air changes per hour) throughout the in-life phase of the study. Temperature and humidity were continuously monitored. The most recent air change verification was reviewed by the study director.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- The vehicle and test article formulations were administered orally by gavage, via a 3-4 inch, 15-18 gauge, animal feeding needle and syringe once daily. Volume administrations did not exceed 3 mL/kg of body weight except for a few instances. The volume administered was based upon the most recent body weight.
- Details on mating procedure:
- A 1:1 mating ratio was used. After dosing on study day 14, the animals were paired by placing the lowest numbered ear tag reproductive group female within each group in the home cage of the male with the lowest numbered ear tag from the same group (one exception was that reproductive group female D1185 was paired with male D1224). Female animals were housed continuously with the same male until evidence of copulation was obtained. Females were evaluated daily for evidence of copulation, as indicated by either a vaginal copulatory plug or sperm in the vaginal smear. Day 0 of gestation was defined as the day evidence of copulation was obtained, at which time the female was returned to her home cage (shoebox cage).
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The concentration of methyltrimethoxysilane (MTMS) in corn oil dosing solutions was determined prior to the beginning of the definitive study.
Preparation of Solvent Standards: Stock solvent standards of MTMS in toluene were prepared under a nitrogen atmosphere by weighing an amount of MTMS and mixing with a known volume of toluene. Aliquots of the stock solution were then further diluted with toluene to cover the standard range from approximately 100 µg MTMS/ml toluene to approximately 1000 µg/ml. New solvent standards were prepared with each dosing solution analysis. An aliquot of each solvent standard was placed in an autosampler vial and analyzed.
Preparation of Dosing Solutions for Analysis of Concentration Verification: Aliquots of dosing formulations were volumetrically measured into volumetric flasks, diluted to volume with toluene and mixed well. Aliquots of the diluted dosing solutions were placed in autosampler vials and were analyzed with the solvent standards for determination of the concentration of MTMS.
Gas Chromatography Analysis: A set of solvent standards comprising of at least five concentrations was used to establish a calibration curve. Trendlines and their mathematical equations were generated by linear regression analysis of the peak areas resulting from the analysis of the solvent standards using Microsoft Excel 2000 (Version 9.0). The dosing solution verifications were performed by comparing the target concentration of the dose solutions to the mean observed test substance concentration found by refitting the peak areas resulting from the dosing solution dilution samples to the standard curve. The limit of quantitation was set at the level of the lowest standard analyzed and was equal to 5 mg MTMS/ml dosing solution. The conditions used were as follows:
Injection: 1 µl, split 50:1
Injector Temp: 160 oC
Carrier Gas: Helium
Column Flow: 1.3 ml/min
Hydrogen Flow: 30 ml/min
Air Flow: 400 ml/min
Combined Flow: 25 ml/min (constant column + make-up flow)
Column: HP-5MS, 30 m x 0.25 mm, 0.25 µm film thickness
Oven Temp: 70 oC for 3 min to 210 oC at 17 oC/min
Detector: Flame Ionization Detector (FID)
Detector Temp: 300 oC
Homogeneity and Stability: Homogeneity and stability of MTMS in corn oil dosing solutions was performed as part of the pilot study with MTMS. The dosing solutions were found to be homogeneous and stable up to 15 days if aliquoted into separate vials for daily usage.
Concentration Verification: Verification of each dosing concentration was conducted following each new preparation. New dosing solutions were prepared at least every 15 days in order to stay within the stability timeframe established in the pilot study.
Results: Dose solution analysis for concentration determined that each batch of 50, 250 and 1000 mg/kg/day dose solution was within 95-07%, 95-97% and 99-100% of the target concentration, respectively. - Duration of treatment / exposure:
- Test substance was administered once daily by oral gavage, seven days per week at approximately the same time each day. Dose levels of methyltrimethoxysilane (MTMS) were 0 (control), 50, 250 and 1000 mg MTMS/kg/day. MTMS, dissolved in corn oil, was administered by oral gavage once each day for up to 51 consecutive days. Females in each dose level were divided into a toxicity (10 animals/group) and a reproductive group (10 animals/group). A single group of males (10 animals/group) were used for both the toxicity and reproductive phases of the study. Toxicity group females and males were treated for 28 and 29 days, respectively. Reproductive group females were treated for 14 days prior to the mating period, during the mating period, and then up to and including post partum day 3, for a total of up to 51 days.
- Frequency of treatment:
- daily
- Details on study schedule:
- Males and toxicity group females were sacrificed after they had been treated for 28 days. Reproductive group females and pups were sacrificed
on day 4 postpartum. A functional observational battery (FOB) evaluation for signs of neurobehavioral effects was performed on all adult males
and all toxicity group females prior to the start of dosing and during the last week of dosing. Body weights and food consumption were recorded
weekly. From all males and all toxicity group females, blood samples were obtained on the day of scheduled necropsy for hematology and
clinical chemistry parameters evaluations. Animals were subjected to a complete gross necropsy. Many tissues and organs were collected for
histological examination and were weighed.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
50, 250, and 1000 mg/kg/day
Basis:
- No. of animals per sex per dose:
- 10/sex/dose level
- Control animals:
- yes, concurrent vehicle
Examinations
- Parental animals: Observations and examinations:
- Mortality/Morbidity: Animals were observed at least twice daily in their cages for moribundity and mortality throughout the in-life phase of the study.
Clinical observations:
Daily Observations: General clinical examinations were made at lease once a day and were conducted immediately after dosing. The examinations included, but were not limited to, changes in the skin, fur, eyes, mucous membranes, respiratory, circulatory, autonomic and central nervous system functions, motor activity and behavior patterns. Findings were recorded for individual animals. General clinical examinations were not performed on days when detailed physical examinations were performed.
Detailed Physical Examinations: All animals received a detailed physical examination once before the first dose administration (to allow for within-subject comparisons), and weekly thereafter. Examinations were made outside the home cage in a standard arena at approximately the same time each day. Observations were detailed and carefully recorded. Examinations included, but were not limited to, changes in skin, fur eyes, mucous membranes, occurrence of secretions and excretions, and autonomic activity. Changes in gait, posture and response to handling as well as the presence of clonic or tonic movement, stereotypies, difficult or prolonged parturition or bizarre behavior were recorded. The presence or absence of findings was recorded for individual animals.
Body weights and food consumption were recorded weekly. Additional body weights for reproductive group females were obtained on gestational day 0, 7, 14, and 20, and within 24 hours of parturition, and on postnatal day 4. Individual food consumption was determined for each group following group specific schedules. In addition, detailed clinical observations (functional observational battery [FOB] conducted out of the home cage) and locomotor activity were evaluated for all adult male and toxicity phase females once prior to the start of test article administration (baseline evaluations) and again during the last week of the test article administration. Blood samples were collected from males and toxicity group females on the day of scheduled termination for analysis of hematology and serum chemistry parameters. - Litter observations:
- All reproductive phase females were allowed to deliver and rear their offspring to lactation day 4; surviving dams and pups were euthanized and examined on lactation day 4.On the day parturition was initiated (PND 0), the pups were sexed and examined for gross malformations, and the numbers of still born and live pups were recorded. Individual gestation length was calculated using the date delivery started. Abnormal behavior of the offspring was recorded. The dam and litter remained together until PND 4.
Mean measured parameters were calculated for:
Days of gestation
Undetermined sex
Male pups/litter
Female pups/litter
Males/Females per litter
Total pups/litter
Viable (live) pups/litter
Viable/Total pups per litter
Initial litter weight at parturition (g)
Initial average pup weight at parturition (g)
Final litter weight at PND 4 (g)
Final average pup weight at PND 4 (g)
Total number of implants
Corpora counts - Postmortem examinations (parental animals):
- Clinical pathology assessments (hematology and serum chemistry) and macroscopic and microscopic examinations (including organ weights) were also performed on the appropriate groups of adult males and toxicity phase females. For females that delivered or had macroscopic evidence of implantation, the numbers of former implantation sites and corpora lutea were recorded. Recognizable fetuses for the females euthanized in extremis were examined externally and preserved in 10% neutral-buffered formalin. For females that failed to deliver, a pregnancy status was determined. Uteri with no macroscopic evidence of implantation were opened and subsequently placed in a 10% ammonium sulfide solution for detection of early implantation loss.
- Postmortem examinations (offspring):
- Intact offspring dying from PND 0 to 4 were necropsied. Cannibalized pups were discarded without necropsy. Tissues were preserved in 10% neutral-buffered formalin for possible future histopathologic examination only as deemed necessary by gross findings. The carcass of each pup was then discarded.
- Statistics:
- Reproductive parameters with the exception of litter size were analyzed using an ANCOVA (Analysis of Covariance) with liter size as the covariate. Litter size was analyzed using an ANOVA.
- Reproductive indices:
- Male (Female) Mating Index (%)
Male Fertility Index (%)
Male Copulation Index (%)
Female Fertility Index (%)
Female Conception Index (%) - Offspring viability indices:
- On the day parturition was initiated (PND 0), the pups were sexed and examined for gross malformations, and the numbers of still born and live pups were recorded.
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- effects observed, treatment-related
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
Reproductive function / performance (P0)
- Reproductive performance:
- no effects observed
Details on results (P0)
"Number pregnant per dose level: 10
"Number aborting: 0 "Number of resorptions, early/late if available: None detected.
"Number of implantations: Group Mean (standard deviation): Control: 15 (2.2); 50 mg/kg: 16 (2.0); 250 mg/kg: 16 (1.4); 1000 mg/kg: 16 (1.9)
"Number of corpora lutea: Group Mean (standard deviation): Control: 19(4.7); 50 mg/kg: 19(3.1); 250 mg/kg:18(2.0); 1000 mg/kg: 17(3.9)
"Duration of Pregnancy: Group Mean (standard deviation): Control: 21 (0.5); 50 mg/kg: 21(0.5); 250 mg/kg: 22(0.5); 1000 mg/kg: 22(0.5)
"Body weight: No statistically significant differences in treatment group maternal body weight relative to control group animals.
"Food/water consumption: No statistically significant differences in treatment group maternal food consumption relative to control group animals.
"Description, severity, time of onset and duration of clinical signs: Thirty percent of the animals in the 50 m/kg/day dose group and 100 % of the animals in the 250 and 1000 mg/kg/day dose groups exhibited a transient period of salivation and/or abnormal inactivity at least once over the course of treatment immediately after dosing.
"Gross pathology incidence and severity: Gross pathology of the reproductive/developmental group animals was not an endpoint for this study.
"Organ weight changes, particularly effects on total uterine weight: Organ weight was not assessed in the reproductive/developmental group animals.
"Histopathology incidence and severity: Histopathology was not assessed in the reproductive/developmental group animals. No treatment-related effects were observed in any of the reproductive parameters evaluated. All females bred successfully and delivered live litters.
There were no treatment-related effects apparent for any of the reproductive endpoints. All females bred successfully and delivered live litters. Litter sizes were comparable for all groups. Differences in group mean values for the treated groups relative to the control group were small and none were found to be statistically significant.
Effect levels (P0)
- Dose descriptor:
- NOAEL
- Effect level:
- >= 1 000 mg/kg bw/day
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Gross pathological findings:
- no effects observed
Details on results (F1)
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- >= 1 000 mg/kg bw/day
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
Result: Exposure to methyltrimethoxysilane was not associated with reproductive toxicity. The findings support a NOAEL of 1000 mg/kg/day.
NOAEL (NOEL) (maternal toxicity): 1000 mg/kg/day
NOAEL (NOEL) (reproductive toxicity): 1000 mg/kg/day
LOAEL (LOEL): N/A
Applicant's summary and conclusion
- Conclusions:
- No data on the reproductive toxicity of trichloro(methyl)silane are available, therefore data on methyltrimethoxysilane have been read-across. The basis for this read-across is that trichloro(methyl)silane and methyltrimethoxysilane are both rapidly hydrolysed to methylsilanetriol. Exposure to methyltrimethoxysilane was not associated with reproductive toxicity. The findings support a NOAEL of at least 1000 mg/kg bw/day. However, since trichloro(methyl)silane is corrosive, additional local effects can be expected for this substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.